Showing results (1041-1050 of 6,495) with videos related to
Sort By:
Pageof 650
Journal of Thrombosis and Haemostasis : JTH|December 21, 2013
Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpuraL A Lotta, C Valsecchi, S Pontiggia, et al.Journal of Thrombosis and Haemostasis : JTH|December 21, 2013
FXIII: mechanisms of action in the treatment of hemophilia AC J Rea, J H Foley, O Okaisabor, et al.Journal of Thrombosis and Haemostasis : JTH|September 5, 2015
Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) StudyJ P Winters, P W Callas, M Cushman, et al.Journal of Thrombosis and Haemostasis : JTH|January 22, 2015
Anti-A2 and anti-A1 domain antibodies are potential predictors of immune tolerance induction outcome in children with hemophilia AP Lapalud, C Rothschild, E Mathieu-Dupas, et al.Journal of Thrombosis and Haemostasis : JTH|August 11, 2017
Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitorsC H Miller, B Boylan, A D Shapiro, et al.Journal of Thrombosis and Haemostasis : JTH|August 11, 2017
Epidemiology of venous thromboembolism in Africa: a systematic reviewC Danwang, M N Temgoua, V N Agbor, et al.Journal of Thrombosis and Haemostasis : JTH|August 12, 2017
ARHGEF10 knockout inhibits platelet aggregation and protects mice from thrombus formationD-H Lu, C-C Hsu, S-W Huang, et al.Journal of Thrombosis and Haemostasis : JTH|August 15, 2017
Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover studyR Kreutz, P B Persson, D Kubitza, et al.Journal of Thrombosis and Haemostasis : JTH|August 15, 2017
Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic reviewG Martillotti, F Boehlen, H Robert-Ebadi, et al.Journal of Thrombosis and Haemostasis : JTH|August 18, 2017
An αIIb β3 antagonist prevents thrombosis without causing Fc receptor γ-chain IIa-mediated thrombocytopeniaY-J Kuo, Y-R Chen, C-C Hsu, et al.Pageof 650